美國的視網膜市場:季報

本報告提供視網膜市場中，每季實施對美國的視網膜的專家的調查，收集資料。將結果分析，每季反映的報告能正確評估、掌握，目前市場情形，以決策流程的改善為目的，含視網膜治療，產品的使用與市場佔有率，產品的採用計劃，醫生的醫藥品、手術器具的評估等。

各更新中，包含全年的預測，與上年度的比較，趨勢分析。

一年4次，美國的視網膜市場上主要指標的檢測、分析。

• 各疾病及各產品的玻璃體內 (IVT) 注射
• Eylea, Lucentis, Avastin, Macugen, Visudyne PDT的使用
• 糖尿病黃斑部水腫 (DME) 治療
• 皮質類固醇的使用
• 光凝固數量和光凝固劑的使用
• 玻璃體切除的數量與位置
• 玻璃體切除機的使用與市場佔有率
• 可重複使用、拋棄式的器具
• 視覺化劑

更新資訊中，包含過去數年收集資訊的比較為基礎的趨勢分析。還有包含美國的視網膜手術 (IVT注射)的全年預測，及與前一年的比較。

Our coverage of the US retina market includes a quarterly surveying process that targets and collects data from retina specialists. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Retina Editions. These editions are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including retinal patient care, product use and market share, product adoption plans, and doctors' evaluations of pharmaceuticals and surgical equipment.

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

Contents:

“The Ophthalmic Market Trends: Quarterly US Retina Editions ” measure and analyze key metrics of the US retinal market four times per year, including:

• IVT injections by disease and product;
• Use of Eylea, Lucentis, Avastin, Macugen, and Visudyne PDT;
• DME treatments;
• Corticosteroid use;
• Photocoagulation volume and photocoagulators used;
• Vitrectomy volume and location;
• Vitrectomy machine use and market share;
• Reusable and disposable instruments.
• Visualization agents

Our updates include trend analysis based on comparisons with information gathered in previous years. We also provide a full-year forecast for US retinal procedures (including IVT injections) and a comparison with volumes during the prior year.